Catalog Home Page

Publications: Berry, Cassandra

Stats for Berry, Cassandra
Export as [feed] RSS
Group by: Publication Type | Year
Jump to: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1983
Number of items: 62.

2014

Cha, L., Berry, C.M., Nolan, D., Castley, A., Fernandez, S. and French, M.A. (2014) Interferon-alpha, immune activation and immune dysfunction in treated HIV infection. Clinical & Translational Immunology, 3 (2). e10.

Rinaldi, C., Penhale, W.J., Stumbles, P.A., Tay, G. and Berry, C.M. (2014) Modulation of innate immune responses by influenza-specific ovine polyclonal antibodies used for prophylaxis. PLoS ONE, 9 (2).

Berry, C.M., Penhale, W.J. and Sangster, M.Y. (2014) Passive broad-spectrum influenza immunoprophylaxis. Influenza Research and Treatment, 2014 (Article ID 267594,).

Strickland, D.H., Fear, V., Shenton, S., Wikstrom, M.E., Zosky, G., Larcombe, A.N., Holt, P.G., Berry, C., von Garnier, C. and Stumbles, P.A. (2014) Persistent and compartmentalised disruption of dendritic cell subpopulations in the lung following influenza A virus infection. PLoS ONE, 9 (11). Article e111520.

2013

Le, X., Poinern, G.E.J., Ali, N., Berry, C.M. and Fawcett, D. (2013) Engineering a biocompatible scaffold with either micrometre or nanometre scale surface topography for promoting protein adsorption and cellular response. International Journal of Biomaterials, 2013 . pp. 1-16.

James-Berry, C.M. (2013) Vaccine control of avian influenza H5N1 in poultry: Need for a positive marker. Journal of Vaccines & Vaccination, 04 (01). p. 168.

2012

Poinern, G.E.J., Ali, N., Berry, C., Singh, P., Berchmans, S. and Fawcett, D. (2012) Biocompatibility of synthesised nano-porous anodic Aluminium oxide membranes for use as a cell culture substrate for Madin-Darby Canine Kidneys cells: A preliminary study. Journal of Tissue Science & Engineering, 3 (3).

Berry, C.M., Hertzog, P.J. and Mangan, N.E. (2012) Interferons as biomarkers and effectors: lessons learned from animal models. Biomarkers in Medicine, 6 (2). pp. 159-176.

2011

Bayer, W., Lietz, R., Ontikatze, T., Johrden, L., Tenbusch, M., Nabi, G., Schimmer, S., Groitl, P., Wolf, H., Berry, C.M., Überla, K., Dittmer, U. and Wildner, O. (2011) Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes. Retrovirology, 8 (1). p. 75.

2010

Chua, T-H, Leung, C.Y.H., Fang, H. E., Chow, Ch-K, Ma, S-K, Sia, S-F, Ng, I.H.Y., Fenwick, S.G., James, C.M., Chua, S.B., Chew, S.T., Kwang, J., Peiris, J.S.M. and Ellis, T.M. (2010) Evaluation of a subunit H5 vaccine and an inactivated H5N2 avian influenza marker vaccine in ducks challenged with Vietnamese H5N1 highly pathogenic avian influenza virus. Influenza Research and Treatment, 2010 . pp. 1-10.

James-Berry, C.M., Middleton, D., Mansfield, J.P., Fenwick, S.G. and Ellis, T.M. (2010) Use of a tetanus toxoid marker to allow differentiation of infected from vaccinated poultry without affecting the efficacy of a H5N1 avian influenza virus vaccine. Veterinary Record, 167 (18). pp. 695-699.

2009

Gerlach, N., Gibbert, K., Alter, C., Nair, S., Zelinskyy, G., James, C.M. and Dittmer, U. (2009) Anti-retroviral effects of type I IFN subtypes in vivo. European Journal of Immunology, 39 (1). pp. 136-146.

Eade, J.A., Robertson, I.D. and James-Berry, C.M. (2009) Contraceptive potential of porcine and feline zona pellucida A, B and C subunits in domestic cats. Reproduction, 137 (6). pp. 913-922.

2008

James-Berry, C.M., Foong, Y.Y., Mansfield, J.P., Vind, A.R., Fenwick, S.G. and Ellis, T.M. (2008) Evaluation of a positive marker of avian influenza vaccination in ducks for use in H5N1 surveillance. Vaccine, 26 (42). pp. 5345-5351.

James, C.M., Duffy, S., Pemberton, D., Armson, A. and Stumbles, P. (2008) Interferon subtype stimulation of dendritic cells: Key activators of anti-viral immunity. Cytokine, 43 (3). p. 309.

2007

James-Berry, C.M., Abdad, M.Y., Mansfield, J.P., Jacobsen, H.K., Vind, A.R., Stumbles, P.A. and Bartlett, E.J. (2007) Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein. Vaccine, 25 (10). pp. 1856-1867.

James, C.M., Lisciandro, J., Gerlach, N., Dittmer, U. and Stumbles, P.A. (2007) Interferon-alpha subtypes differentially enhance dendritic cell biology. In: International Society for Interferon and Cytokine Research, Interferon Anniversary Meeting, 16 - 19 September, Oxford, England

James-Berry, C.M., Foong, Y.Y., Mansfield, J.P., Fenwick, S.G. and Ellis, T.M. (2007) Use of tetanus toxoid as a differentiating infected from vaccinated animals (DIVA) strategy for sero-surveillance of avian influenza virus vaccination in poultry. Vaccine, 25 (31). pp. 5892-5901.

2006

Austin, B.A., James-Berry, C.M., Härle, P. and Carr, D.J.J. (2006) Direct application of plasmid DNA containing type I interferon transgenes to vaginal mucosa inhibits HSV-2 mediated mortality. Biological Procedures Online, 8 (1). pp. 55-62.

2005

Austin, B.A., James, C., Silverman, R.H. and Carr, D.J.J. (2005) Critical role for the oligoadenylate synthetase/RNase L pathway in response to IFN-β during acute ocular herpes simplex virus type 1 infection. Journal of Immunology, 175 (2). pp. 1100-1106.

James, C.M., Bartlett, E.J., Mansfield, J.P. and Cull, V.S. (2005) Interferon subtype gene therapy for regulating cytomegalovirus disease. Methods in molecular medicine, 116 . pp. 207-219.

2004

Bartlett, E.J., Lenzo, J.C., Sivamoorthy, S., Mansfield, J.P., Cull, V.S. and James, C.M. (2004) Type I IFN-beta gene therapy suppresses cardiac CD8+ T-cell infiltration during autoimmune myocarditis. Immunology and Cell Biology, 82 (2). pp. 119-126.

2003

Lenzo, J.C., Mansfield, J.P., Sivamoorthy, S., Cull, V.S. and James, C.M. (2003) Cytokine expression in murine cytomegalovirus-induced myocarditis: modulation with interferon-α therapy. Cellular Immunology, 223 (1). pp. 77-86.

Carr, D.J.J., Al-khatib, K., James, C.M. and Silverman, R. (2003) Interferon-β suppresses herpes simplex virus type 1 replication in trigeminal ganglion cells through an RNase L-dependent pathway. Journal of Neuroimmunology, 141 (1-2). pp. 40-46.

Bartlett, E.J., Cull, V.S., Mowe, E.N., Mansfield, J.P. and James, C.M. (2003) Optimization of naked DNA delivery for interferon subtype immunotherapy in cytomegalovirus infection. Biological Procedures Online, 5 (1). pp. 43-52.

Cull, V.S., Tilbrook, P.A., Bartlett, E.J., Brekalo, N.L. and James, C.M. (2003) Type I interferon differential therapy for erythroleukemia: Specificity of STAT activation. Blood, 101 (7). pp. 2727-2735.

2002

Lenzo, J.C., Fairweather, D., Cull, V., Shellam, G.R. and James, C.M. (2002) Characterisation of murine cytomegalovirus myocarditis: Cellular infiltration of the heart and virus persistence. Journal of Molecular and Cellular Cardiology, 34 (6). pp. 629-640.

Cull, V.S., Broomfield, S., Bartlett, E.J., Brekalo, N.L. and James, C.M. (2002) Coimmunisation with type I IFN genes enhances protective immunity against cytomegalovirus and myocarditis in gB DNA-vaccinated mice. Gene Therapy, 9 (20). pp. 1369-1378.

Harle, P., Cull, V., Agbaga, M-P, Silverman, R., Williams, B.R.G., James, C. and Carr, D.J.J. (2002) Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication. Journal of Virology, 76 (13). pp. 6558-6567.

Carr, D.J., Cull, V. and James, C.M. (2002) Mouse cornea transfected with plasmid containing interferon-b transgene is superior to other Type I interferon transgenes in antagonizing viral-medicated mortality. In: Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), 5 - 10 May, Fort Lauderdale, Florida, USA.

Bartlett, E.J., Cull, V.S., Brekalo, N.L., Lenzo, J.C. and James, C.M. (2002) Synergy of type I interferon-A6 and interferon-B naked DNA immunotherapy for cytomegalovirus infection. Immunology and Cell Biology, 80 (5). pp. 425-435.

Härle, P., Cull, V., Guo, L., Papin, J., Lawson, C. and Carr, D.J.J. (2002) Transient transfection of mouse fibroblasts with type I interferon transgenes provides various degrees of protection against herpes simplex virus infection. Antiviral Research, 56 (1). pp. 39-49.

Cull, V.S., Bartlett, E.J. and James, C.M. (2002) Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis. Immunology, 106 (3). pp. 428-437.

2001

Lenzo, J.C. and Lawson, C.M. (2001) Cytomegalovirus-induced myocarditis - An animal model for understanding pathogenesis and therapy. International Antiviral News, 9 (11). pp. 166-169.

Fairweather, D., Kaya, Z., Shellam, G.R., Lawson, C.M. and Rose, N.R. (2001) From infection to autoimmunity. Journal of Autoimmunity, 16 (3). pp. 175-186.

Lenzo, J.C., Shellam, G.R. and Lawson, C.M. (2001) Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice. Antimicrobial agents and chemotherapy, 45 (5). pp. 1444-1449.

Lenzo, J.C., Fairweather, D., Shellam, G.R. and Lawson, C.M. (2001) Immunomodulation of murine cytomegalovirus-induced myocarditis in mice treated with lipopolysaccharide and tumor necrosis factor. Cellular Immunology, 213 (1). pp. 52-61.

2000

Lawson, C.M. (2000) Evidence for mimicry by viral antigens in animal models of autoimmune disease including myocarditis. Cellular and Molecular Life Sciences, 57 (4). pp. 552-560.

1999

Bosio, E., Beilharz, M.W., Watson, M.W. and Lawson, C.M. (1999) Efficacy of low-dose oral use of type I interferon in cytomegalovirus infections in vivo. Journal of Interferon & Cytokine Research, 19 (8). pp. 869-876.

Lawson, C.M. and Beilharz, M.W. (1999) Low-dose oral use of interferon inhibits virally induced myocarditis. Journal of Interferon & Cytokine Research, 19 (8). pp. 863-867.

1998

Yeow, W.S., Lawson, C.M. and Beilharz, M.W. (1998) Antiviral activities of individual murine IFN-alpha subtypes in vivo: intramuscular injection of IFN expression constructs reduces cytomegalovirus replication. Journal of Immunology, 160 (6). pp. 2932-2939.

Fairweather, D., Lawson, C.M., Chapman, A.J., Brown, C.M.S., Booth, T.W.M., Papadimitriou, J.M. and Shellam, G.R. (1998) Wild isolates of murine cytomegalovirus induce myocarditis and antibodies that cross-react with virus and cardiac myosin. Immunology, 94 (2). pp. 263-270.

1997

Lawson, C.M., Yeow, W-S, Lee, C.M. and Beilharz, M.W. (1997) In vivo expression of an interferon-α gene by intramuscular injection of naked DNA. Journal of Interferon & Cytokine Research, 17 (5). pp. 255-261.

Beilharz, M.W., McDonald, W., Watson, M.W., Heng, J., McGeachie, J. and Lawson, C.M. (1997) Low-dose oral type I interferons reduce early virus replication of murine cytomegalovirus in vivo. Journal of Interferon & Cytokine Research, 17 (10). pp. 625-630.

Epstein, S.L., Lo, C.Y., Misplon, J.A., Lawson, C.M., Hendrickson, B.A., Max, E.E. and Subbarao, K. (1997) Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice. The Journal of Immunology, 158 (3). pp. 1222-1230.

Blechynden, L.M., Lawson, M.A., Tabarias, H., Garlepp, M.J., Sherman, J., Raben, N. and Lawson, C.M. (1997) Myositis induced by naked DNA immunization with the gene for Histidyl-tRNA synthetase. Human Gene Therapy, 8 (12). pp. 1469-1480.

1996

Blechynden, L.M., Lawson, C.M. and Garlepp, M.J. (1996) Sequence and polymorphism analysis of the murine gene encoding histidyl-tRNA synthetase. Gene, 178 (1-2). pp. 151-156.

1995

Subbarao, E.K., Park, E.J., Lawson, C.M., Chen, A.Y. and Murphy, B.R. (1995) Sequential addition of temperature-sensitive missense mutations into the PB2 gene of influenza A transfectant viruses can effect an increase in temperature sensitivity and attenuation and permits the rational design of a genetically engineered live influenza A virus vaccine. Journal of Virology, 69 (10). pp. 5969-5799.

1994

Lawson, C.M., Bennink, J.R., Restifo, N.P., Yewdell, J.W. and Murphy, B.R. (1994) Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge. Journal of Virology, 68 (6). pp. 3505-3511.

1993

Epstein, S.L., Misplon, J.A., Lawson, C.M., Subbarao, E.K., Connors, M. and Murphy, B.R. (1993) Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase. Journal of Immunology, 150 (12). pp. 5484-5493.

Lawson, C.M., Subbarao, E.K. and Murphy, B.R. (1993) Erratum: Nucleotide sequence changes in the polymerase basic protein 2 gene of temperature-sensitive mutants of influenza A virus (Virology (506- 510)). Virology, 195 (1). p. 302.

1992

Lawson, C.M., O'Donoghue, H.L., Bartholomaeus, W.H. and Reed, W.D. (1992) Genetic control of mouse cytomegalovirus-induced myocarditis. Immunology, 69 (1). pp. 20-26.

Lawson, C.M., O'Donoghue, H.L. and Reed, W.D. (1992) Mouse cytomegalovirus infection induces antibodies which cross-react with virus and cardiac myosin: a model for the study of molecular mimicry in the pathogenesis of viral myocarditis. Immunology, 75 (3). pp. 513-519.

Lawson, C.M., Subbarao, E.K. and Murphy, B.R. (1992) Nucleotide sequence changes in the polymerase basic protein 2 gene of temperature-sensitive mutants of influenza A virus. Virology, 191 (1). pp. 506-510.

1991

Lawson, C.M., O'Donoghue, H.L., Farrell, H.E., Shellam, G.R. and Reed, W.D. (1991) Murine anti-cytomegalovirus monoclonal antibodies with autoreactivity. Immunology, 72 (3). pp. 426-433.

1990

O'Donoghue, H.L., Lawson, C.M. and Reed, W.D. (1990) Autoantibodies to cardiac myosin in mouse cytomegalovirus myocarditis. Immunology, 71 (1). pp. 20-28.

1989

Lawson, C.M., O'Donoghue, H.L. and Reed, W.D. (1989) The role of T cells in mouse cytomegalovirus myocarditis. Immunology, 67 (1). pp. 132-134.

Lawson, C.M., Hodgkin, P.D. and Shellam, G.R. (1989) The effect of cyclosporin on major histocompatibility complex-linked resistance to murine cytomegalovirus. Journal of General Virology, 70 (5). pp. 1253-1259.

1988

Bartholomaeus, W.N., O'Donoghue, H., Foti, D., Lawson, C.M., Shellam, G.R. and Reed, W.D. (1988) Multiple autoantibodies following cytomegalovirus infection: virus distribution and specificity of autoantibodies. Immunology, 64 (3). pp. 397-405.

Lawson, C.M., Grundy, J.E. and Shellam, G.R. (1988) Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice. Journal of General Virology, 69 (8). pp. 1987-1998.

1987

Lawson, C.M., Grundy, J.E. and Shellam, G.R. (1987) Delayed-type hypersensitivity responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice. Journal of General Virology, 68 (9). pp. 2379-2388.

1983

James, C.M. (1983) Australia's microbiological role in the third world. Australian Microbiologist . pp. 4-8.

This list was generated on Thu Nov 27 09:29:32 2014 GMT.